Nisa Investment Advisors LLC Has $27,000 Stock Position in AdaptHealth Corp. (NASDAQ:AHCO)

Nisa Investment Advisors LLC boosted its stake in shares of AdaptHealth Corp. (NASDAQ:AHCOGet Rating) by 96.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,710 shares of the company’s stock after purchasing an additional 840 shares during the quarter. Nisa Investment Advisors LLC’s holdings in AdaptHealth were worth $27,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of AHCO. Russell Investments Group Ltd. bought a new position in shares of AdaptHealth during the 4th quarter worth about $405,000. Allspring Global Investments Holdings LLC bought a new position in AdaptHealth during the fourth quarter valued at about $950,000. Dupont Capital Management Corp acquired a new position in AdaptHealth in the 4th quarter valued at approximately $374,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of AdaptHealth by 98.1% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 11,966 shares of the company’s stock worth $293,000 after acquiring an additional 5,927 shares during the period. Finally, Sumitomo Mitsui Trust Holdings Inc. acquired a new stake in shares of AdaptHealth during the 4th quarter worth approximately $45,097,000. 83.68% of the stock is owned by institutional investors.

AdaptHealth Trading Up 0.8 %

Shares of AHCO stock opened at $22.11 on Monday. The company has a market capitalization of $2.97 billion, a P/E ratio of 40.20, a P/E/G ratio of 0.30 and a beta of 0.43. AdaptHealth Corp. has a 12-month low of $11.40 and a 12-month high of $28.75. The company has a quick ratio of 1.16, a current ratio of 1.39 and a debt-to-equity ratio of 1.03. The firm has a 50-day moving average price of $18.77 and a 200 day moving average price of $17.21.

AdaptHealth (NASDAQ:AHCOGet Rating) last posted its earnings results on Tuesday, May 10th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.21 by ($0.23). The firm had revenue of $706.20 million during the quarter, compared to the consensus estimate of $646.42 million. AdaptHealth had a net margin of 7.54% and a return on equity of 7.77%. The business’s revenue was up 46.5% on a year-over-year basis. During the same quarter last year, the firm posted $0.17 EPS. Research analysts forecast that AdaptHealth Corp. will post 1.47 earnings per share for the current fiscal year.

Insider Transactions at AdaptHealth

In other AdaptHealth news, Director Skyknight Capital Fund Ii, L.P purchased 100,000 shares of the business’s stock in a transaction that occurred on Friday, May 20th. The stock was acquired at an average cost of $17.33 per share, with a total value of $1,733,000.00. Following the completion of the acquisition, the director now directly owns 2,784,543 shares of the company’s stock, valued at approximately $48,256,130.19. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Over the last quarter, insiders have acquired 350,390 shares of company stock worth $6,016,723. Insiders own 17.30% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on AHCO. Truist Financial upped their target price on AdaptHealth from $20.00 to $24.00 and gave the company a “buy” rating in a research note on Thursday, July 14th. TheStreet lowered shares of AdaptHealth from a “c-” rating to a “d+” rating in a research report on Friday, April 29th. Deutsche Bank Aktiengesellschaft lowered their target price on shares of AdaptHealth from $28.00 to $22.00 in a research note on Wednesday, May 11th. Finally, Canaccord Genuity Group cut their price target on shares of AdaptHealth from $29.00 to $26.00 and set a “buy” rating for the company in a research note on Thursday, May 12th. Four equities research analysts have rated the stock with a buy rating, According to data from, AdaptHealth presently has an average rating of “Buy” and an average target price of $24.67.

About AdaptHealth

(Get Rating)

AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.

See Also

Want to see what other hedge funds are holding AHCO? Visit to get the latest 13F filings and insider trades for AdaptHealth Corp. (NASDAQ:AHCOGet Rating).

Institutional Ownership by Quarter for AdaptHealth (NASDAQ:AHCO)

Want More Great Investing Ideas?

Receive News & Ratings for AdaptHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdaptHealth and related companies with's FREE daily email newsletter.